CPRiL

C17H11F6N7O

C1=CN=C(C=N1)NNC(=O)/C=C\N2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F

InChI=1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1-

• Selinexor
• KPT-330
• 1393477-72-9
Xpovio
Selinexor (KPT-330)
(Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide
Selinexor free base
KPT 330
selinexorum
UNII-31TZ62FO8F
31TZ62FO8F
2-Propenoic acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-, 2-(2-pyrazinyl)hydrazide, (2Z)-
2-Propenoic acid, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2Z)-
KPT330
(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide
(2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide
1621865-82-4
compound 70 (WO2013019561A1)
compound 70 [WO2013019561A1]
Selinexor [USAN:INN]
Nexpovio
Selinexor [INN]
KPT330;Selinexor
Xpovio (TN)
KPT-330(Selinexor)
SELINEXOR [MI]
Selinexor (USAN/INN)
SELINEXOR [USAN]
SELINEXOR [WHO-DD]
SINE KPT-330